Skip to main content
Biofrontera AG logo

Biofrontera AG — Investor Relations & Filings

Ticker · B8F ISIN · DE000A4BGGM7 LEI · 391200D6GFSVFGFQTL13 F Manufacturing
Filings indexed 120 across all filing types
Latest filing 2024-05-02 Annual Report (ESEF)
Country DE Germany
Listing F B8F

About Biofrontera AG

https://www.biofrontera.com/en/

Biofrontera AG is a biopharmaceutical company that specializes in dermatology. The company develops and markets innovative products for the treatment, care, and protection of the skin. Its core expertise is in photodynamic therapy (PDT), a non-invasive treatment for various skin conditions. Biofrontera's products are primarily focused on treating forms of non-melanoma skin cancer, such as actinic keratosis, field cancerization, and basal cell carcinoma. The portfolio includes both dermatological drugs and medical cosmetics.

Recent filings

Filing Released Lang Actions
Konzernabschluss zum Geschäftsjahr vom 01.01.2023 bis zum 31.12.2023
Annual Report (ESEF) Classification · 100% confidence FY 2023
2024-05-02 German
Annual Report 2023
Annual Report Classification · 99% confidence The document explicitly titles itself as 'Biofrontera AG – Annual Report 2023' and contains a detailed Table of Contents listing sections typical of an annual report, such as 'Letter to shareholders', 'Consolidated balance sheet', 'Consolidated statement of comprehensive income', 'Consolidated cash flow statement', and 'Independent Auditor's Report'. Furthermore, it presents key financial figures for the full year 2023 compared to 2022, including sales revenue, EBITDA, and balance sheet items, which are the core components of a comprehensive annual filing. Although it contains ESG/sustainability discussions, the primary structure and content align with the definition of an Annual Report (10-K equivalent for non-US filers, or a comprehensive annual filing). Since the provided codes include '10-K' for the official yearly report covering full financial performance, this is the most appropriate classification. FY 2023
2024-04-29 English
Hinweis auf Konzernabschluss vom 01.01.2023 bis zum 31.12.2023
Report Publication Announcement Classification · 100% confidence The document is a short notification (approx. 1010 characters) announcing the upcoming availability of the 2023 annual group report. It explicitly states 'Pre-announcement of a financial report' and provides a link to where the report will be available. Per the 'Menu vs Meal' rule, this is an announcement of a report rather than the report itself, making it a Report Publication Announcement (RPA).
2024-04-24 German
Hinweis auf Konzernabschluss vom 01.01.2023 bis zum 31.12.2023
Report Publication Announcement Classification · 99% confidence The document is very short (1020 characters) and explicitly states that financial reports ('year report of the group 2023') 'shall be disclosed' and provides a link where the report is available starting on 30.04.2024. The text itself is a 'Pre-announcement of a financial report'. According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement stating that a report is published or available elsewhere classifies as a Report Publication Announcement (RPA), not the full report itself (like 10-K or IR).
2024-04-24 German
Halbjahresfinanzbericht nach WpHG für den Zeitraum vom 01.01.2023 bis zum 30.06.2023
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Halbjahresfinanzbericht' (Half-Year Financial Report) for Biofrontera AG, covering the period from 01.01.2023 to 30.06.2023. It contains detailed financial statements, including balance sheets, income statements (Ertragslage), and management discussion (Konzernzwischenlagebericht). As it is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial data, it is classified as an Interim/Quarterly Report. H1 2023
2023-08-31 German
Hinweis auf Halbjahresfinanzbericht vom 01.01.2023 bis zum 30.06.2023
Report Publication Announcement Classification · 100% confidence The document is a short announcement (under 5,000 characters) that explicitly states it is a 'Pre-announcement of a financial report' and provides a link to where the actual report can be found. Following the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA) rather than the financial report itself.
2023-08-18 German

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.